全文获取类型
收费全文 | 4578篇 |
免费 | 463篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 37篇 |
儿科学 | 158篇 |
妇产科学 | 90篇 |
基础医学 | 661篇 |
口腔科学 | 209篇 |
临床医学 | 562篇 |
内科学 | 802篇 |
皮肤病学 | 80篇 |
神经病学 | 272篇 |
特种医学 | 151篇 |
外科学 | 622篇 |
综合类 | 110篇 |
一般理论 | 3篇 |
预防医学 | 418篇 |
眼科学 | 43篇 |
药学 | 262篇 |
中国医学 | 2篇 |
肿瘤学 | 568篇 |
出版年
2021年 | 69篇 |
2020年 | 51篇 |
2019年 | 69篇 |
2018年 | 96篇 |
2017年 | 70篇 |
2016年 | 50篇 |
2015年 | 71篇 |
2014年 | 106篇 |
2013年 | 171篇 |
2012年 | 196篇 |
2011年 | 184篇 |
2010年 | 118篇 |
2009年 | 113篇 |
2008年 | 174篇 |
2007年 | 168篇 |
2006年 | 176篇 |
2005年 | 171篇 |
2004年 | 165篇 |
2003年 | 142篇 |
2002年 | 150篇 |
2001年 | 125篇 |
2000年 | 143篇 |
1999年 | 149篇 |
1998年 | 85篇 |
1997年 | 87篇 |
1996年 | 79篇 |
1995年 | 71篇 |
1994年 | 61篇 |
1993年 | 64篇 |
1992年 | 90篇 |
1991年 | 106篇 |
1990年 | 104篇 |
1989年 | 110篇 |
1988年 | 97篇 |
1987年 | 76篇 |
1986年 | 93篇 |
1985年 | 76篇 |
1984年 | 59篇 |
1983年 | 50篇 |
1982年 | 36篇 |
1981年 | 43篇 |
1980年 | 46篇 |
1979年 | 53篇 |
1978年 | 41篇 |
1976年 | 41篇 |
1973年 | 57篇 |
1972年 | 43篇 |
1971年 | 40篇 |
1969年 | 37篇 |
1967年 | 37篇 |
排序方式: 共有5050条查询结果,搜索用时 0 毫秒
61.
Miguel H. Bronchud Jennifer M. Margison Anthony Howell Michael Lind Samuel B. Lucas Peter M. Wilkinson 《Cancer chemotherapy and pharmacology》1990,25(6):435-439
Summary Recombinant human granulocyte colony-stimulating factor (G-CSF) has been shown to reduce neutropenia following cytotoxic therapy, thereby enabling dose escalation to improve the response rate. It is important to know whether drug kinetics change as doses are increased. Doxorubicin was selected because of its broad spectrum of activity and its known efficacy in metastatic breast cancer. Doses of 75, 100, 125 and 150 mg/m2 were given to 11 patients with metastatic breast cancer by infusion over 30 min. Serum concentrations of parent drug and metabolites were determined during the first 48 h following the infusion by high-performance liquid chromatography (HPLC). The serum concentration vs time curve decayed as a triple exponential function in four patients and as a double exponential function in seven. A four-compartment model, one central and three peripheral, would predict concentrations to within 1 SE of the observed values. Doxorubicinol was the principal metabolite, and doxorubicinone and 7-deoxydoxorubicinone were clearly identified. There was a linear increase in the AUC with dose. In addition, a small and transient increase in circulating levels of doxorubicinol and other important metabolites was observed 6 h following the administration of doxorubicin, which suggests the existence of an enterohepatic, or other, re-circulation mechanism. We conclude that in the dose range selected the kinetics of doxorubicin are linear and that the increase in toxicities seen with the higher doses of doxorubicin, following the second and third fortnightly administration, may be due to intracellular drug accumulation in tissues. 相似文献
62.
63.
Longo DR Kruse RL LeFevre ML Schramm WF Stockbauer JW Howell V 《Journal of health care finance》1999,25(3):75-89
The objective of this study was to examine the relationship of nonmedical factors, including socioeconomic status, social class, education, race, and social support, to low birth weight. In a case-control study of all resident very-low-birth-weight births between December 1, 1989, and March 31, 1991, mothers completed an extensive survey related to their experience of pregnancy, including prenatal and postnatal care. Cases were defined as very-low-birth-weight (VLBW) infants and were matched to moderately-low-birth-weight and normal-birth-weight infants in race, age, and maternal residence. The hypothesis that social and class factors are more predictive of low birth weight than medical factors alone for women without chronic health problems was supported. Although the degree of the association varies depending on birth weight outcome, race even though addressed through matching--continued to play an important role in birth outcomes. A comparison of logistic model performance with and without the inclusion of social factors indicated the importance these variables play in prediction of birth outcomes. This is one of the few studies undertaken that explicitly investigates impact of patient factors on medical care. 相似文献
64.
65.
Diagnosis and management of BK polyomavirus interstitial nephritis in renal transplant recipients 总被引:18,自引:0,他引:18
Howell DN Smith SR Butterly DW Klassen PS Krigman HR Burchette JL Miller SE 《Transplantation》1999,68(9):1279-1288
BACKGROUND: Interstitial nephritis caused by BK polyomavirus is a recognized complication of renal transplantation. A study of renal transplant recipients at Duke University Medical Center was undertaken to evaluate diagnostic modalities and assess clinical outcomes in transplant polyomavirus infections. METHODS: Polyomavirus nephritis was identified in 6 of 240 patients who received renal transplants between January 1996 and June 1998 and an additional patient who underwent transplantation in 1995. The clinical records of these seven patients were reviewed, as were all renal biopsy and nephrectomy specimens. Electron microscopy (EM) was performed on negatively stained urine samples from 6 patients with polyomavirus infection and 23 patients with other diagnoses. RESULTS: Patients with polyomavirus infection shared several clinical features, including ureteral obstruction (5/7 patients), lymphocele (3/7), bacterial urinary tract infection (3/7), hematuria (3/7), cytomegalovirus infection (3/7), and immunosuppression with mycophenolate mofetil (6/7). All patients experienced elevations in serum creatinine, which stabilized or decreased in four patients with altered or decreased immunosuppression. The diagnosis of polyomavirus infection was established by renal biopsy and EM of urine in five patients, by biopsy alone in one, and by EM alone in one. Sequential examinations of urine by EM were used to monitor the course of infection in six patients. CONCLUSIONS: Interstitial nephritis due to BK polyomavirus occurred in 2.5% of patients receiving renal transplants at our center since 1996. Polyomavirus infection can cause transplant dysfunction and graft loss, but progression of the infection can frequently be abrogated with alterations in immunosuppressive therapy. Both renal biopsy and EM of urine samples are useful in the diagnosis and monitoring of polyomavirus infections. 相似文献
66.
67.
Pathways to care for alcohol use disorders 总被引:1,自引:0,他引:1
68.
Effect of loss of DNA mismatch repair on development of topotecan-, gemcitabine-, and paclitaxel-resistant variants after exposure to cisplatin. 总被引:1,自引:0,他引:1
Loss of DNA mismatch repair (MMR) causes genomic instability by markedly increasing the frequency of sporadic mutations in both coding and noncoding sequences. Little is known about how loss of MMR affects sensitivity to the mutagenic effect of chemotherapeutic agents. We wanted to determine how loss of MMR affects the ability of cisplatin, a known mutagen, to generate human tumor cell variants resistant to other drugs with which cisplatin is commonly combined in treatment regimens. We compared the ability of cisplatin to produce variants resistant to topotecan, gemcitabine, and paclitaxel in two pairs of MMR-proficient and -deficient cells that included sublines of the human colon carcinoma cell line HCT-116 and sublines of the human endometrial adenocarcinoma cell line HEC59. Cells were exposed to increasing concentrations of cisplatin for 1 h, and the surviving population was tested for the frequency of variants resistant to these single molecular target drugs 10 days later. The frequency of variants increased linearly with cisplatin concentration for all three drugs. Cisplatin was 2.6 +/- 0.3- (S.D.), 3.6 +/- 0.9-, and 2.3 +/- 0.1-fold more potent at producing topotecan-, gemcitabine-, and paclitaxel-resistant variants in the MMR-deficient than in the MMR-proficient HCT116 cells (P <.05 for all). Cisplatin was 1.4 +/- 0.3- and 1.4 +/- 0.4-fold more potent at generating topotecan- and gemcitabine-resistant variants in MMR-deficient HEC59 cells than in MMR-proficient HEC59+ch2 cells. Cisplatin was not more potent in generating paclitaxel-resistant variants in the MMR-deficient HEC59 cells. Spontaneous rates of generation of cells resistant to these three drugs were also measured in the HCT116 sublines. MMR-deficient HCT116 cells exhibited rates of generation of resistant variants that were 1.94- and 1.51-fold higher (P <.05) than those in the MMR-proficient cells for topotecan and gemcitabine, respectively; loss of MMR had no effect on the rate of generation of variants resistant to paclitaxel. We conclude that the loss of MMR increases the ability of cisplatin to generate variants resistant to topotecan, gemcitabine, and possibly paclitaxel and that MMR also plays a role in controlling the spontaneous rate of generation of variants resistant to topotecan and gemcitabine. 相似文献
69.
70.
G L Bernardini B A Rampy G A Howell D J Hayes C J Frederickson 《Journal of neuroscience methods》1991,38(1):81-88
Piezoelectric pumps or "jets" are used in industry for precise dispensing of small volumes of fluids. In the present work we have tested the feasibility of using these piezoelectric devices for dispensing fluids in neurobiological research. In one experiment, 70 picoliter (pl) droplets of histochemical reagent were jetted onto discrete targets of frozen tissue sections, and qualitative and quantitative histochemical studies were done on the small (170 microns diameter) circle of tissue wet by the droplets. In the second experiment, 70 pl droplets of neuroactive drugs were jetted onto brain tissue slices while recording single neurons extracellularly in vitro, and the effects of the drugs were found to vary systematically as a function of the number of drops and the distance between drop application and the recorded neuron. The results indicate that piezoelectric jets could have wide application for dispensing fluids in neurobiological research. 相似文献